Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy.

Young, M J; Marshall, A; Adams, J E; Selby, P L; Boulton, A J · Diabetes Care · 1995

cross_sectional · Level IV

Where this comes from

Abstract

To determine factors that might be associated with the development of Charcot neuroarthropathy. This cross-sectional prevalence study examined neurological function and bone density in matched groups of neuropathic diabetic patients with and without radiological evidence of Charcot neuroarthropathy. Patients with Charcot neuroarthropathy had a global impairment of neurological function that was significantly greater than that of otherwise matched non-Charcot neuropathic patients. All 17 Charcot patients had evidence of autonomic neuropathy compared with 10 of the control subjects (P = 0.03). The Charcot patients had evidence of reduced bone density in the lower limbs compared with the neuropathic control subjects (P = 0.009), but relatively preserved bone density in the spine (P = 0.4 vs. control subjects). We conclude that minor trauma in diabetic patients with peripheral neuropathy might result in a fracture in those with a reduced bone density and thus trigger the development of Charcot neuroarthropathy.

Medical subject headings